Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02307617 · ClinicalTrials.gov registry record
Glutamate Probes in Adolescent Depression
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 57
- Enrollment target
NCT02307617: Completed study, sponsored by Mayo Clinic.
NCT02307617 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02307617 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if measures of brain chemicals from a brain scan called Magnetic Resonance Imaging and Spectroscopy (MRI/MRS) and brain activity (known as cortical excitability and inhibition) collected by Transcranial Magnetic Stimulation (TMS) are different in adolescents with depression who are in different stages of treatment. Researchers are conducting this study to learn more about how the brain works in adolescents with depression and without depression (healthy controls). This is important because it may identify a biological marker (a measure of how bad an illness is) for depression that could one day be used to identify depressed adolescents who would benefit from certain treatments (medications for example) or to monitor how well treatments are working.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2014-08-01 |
| Est. Completion | 2017-04-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02307617
The ClinicalTrials.gov registry entry for NCT02307617 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02307617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02307617 about?
NCT02307617 is a clinical study titled "Glutamate Probes in Adolescent Depression". The purpose of this study is to learn if measures of brain chemicals from a brain scan called Magnetic Resonance Imaging and Spectroscopy (MRI/MRS) and brain activity (known as cortical excitability and inhibition) collected by Transcranial Magnetic Stimulation (TMS) are different in adolescents wit...
What is the current status of trial NCT02307617?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2014-08-01. Estimated completion is 2017-04-17.
Who is sponsoring clinical trial NCT02307617?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.